UOC
AXNX

UBS O'Connor’s Axonics, Inc. Common Stock AXNX Stock Holding History

UBS O'Connor’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,148,826
Closed -$150M – 609
2024
Q3 		$150M Sell
2,148,826
-48,454
-2% -$3.32M 3.69% 9
2024
Q2 		$148M Buy
2,197,280
+251,360
+13% +$16.9M 4.16% 6
2024
Q1 		$134M Buy
1,945,920
+1,897,614
+3,928% +$128M 3.85% 6
2023
Q4 		$3.01M Sell
48,306
-2,370
-5% -$133K 0.09% 119
2023
Q3 		$2.84M Sell
50,676
-3,000
-6% -$169K 0.05% 181
2023
Q2 		$2.71M Buy
53,676
+2,644
+5% +$141K 0.06% 214
2023
Q1 		$2.78M Buy
+51,032
New +$2.98M 0.07% 217
2022
Q4 		– Sell
-32,613
Closed -$2.3M – 412
2022
Q3 		$2.3M Hold
32,613
– – 0.03% 599
2022
Q2 		$1.85M Buy
+32,613
New +$1.79M 0.02% 671

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS O'Connor's AXNX Position: Q4 2024 in Review

UBS O'Connor sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 2,148,826 shares — an estimated $150M sold.

UBS O'Connor first reported a position in AXNX in Q2 2022 and held it in 9 quarters. The position peaked at $150M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • UBS O'Connor reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • UBS O'Connor sold 2,148,826 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $150M.
  • UBS O'Connor first reported a position in Axonics, Inc. Common Stock in Q2 2022 and held it in 9 quarters.
  • UBS O'Connor's Axonics, Inc. Common Stock position peaked at $150M in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.